The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer

Vincenzo Valentini, Maria Antonietta Gambacorta, Francesco Cellini, Claudio Coco, Brunella Barbaro, Sergio Alfieri, Domenico D'Ugo, Roberto Persiani, Francesco Deodato, Antonio Crucitti, Maria Cristina Barba, Fabio Maria Vecchio, Alessio Giuseppe Morganti, Giuseppe La Torre, Marco Lupattelli, Federico Navarria, Claudio Belluco, Angela Buonadonna, Caterina Boso, Sara LonardiLuciana Caravatta, Ernesto Maranzano, Salvatore Pucciarelli, Antonio De Paoli

Research output: Contribution to journalArticle

13 Citations (Scopus)

Abstract

N/A
Original languageEnglish
Pages (from-to)110-118
Number of pages9
JournalRadiotherapy and Oncology
Volume134
DOIs
Publication statusPublished - 2019

Keywords

  • Boost
  • Chemoradiation
  • Oxaliplatin
  • Pathologic complete response
  • Preoperative radiochemotherapy
  • Rectal cancer

Fingerprint

Dive into the research topics of 'The INTERACT Trial: Long-term results of a randomised trial on preoperative capecitabine-based radiochemotherapy intensified by concomitant boost or oxaliplatin, for cT2 (distal)-cT3 rectal cancer'. Together they form a unique fingerprint.

Cite this